Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.
D000328:Adult; D000368:Aged; D002545:Brain Ischemia / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000134:cerebrospinal fluid; D006801:Humans; D002532:Intracranial Aneurysm / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012422:Rupture, Spontaneous; D013345:Subarachnoid Hemorrhage / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D014148:Tranexamic Acid / Q000009:adverse effects / Q000134:cerebrospinal fluid / Q000627:therapeutic use*
D003509:Cyclohexanecarboxylic Acids; D005338:Fibrin Fibrinogen Degradation Products; D014148:Tranexamic Acid